SCHEMBL6214970

SCHEMBL6214970

O=S(=O)(NC1CCN(C(CF)Cc2coc3ccccc23)CC1)c1cccc2cnccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 5/20 0.44
DRD2 P14416 3/20 0.44
HTR2A P28223 3/20 0.44
HTR6 P50406 3/20 0.44
HTR1A P08908 3/20 0.41
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
P2RX7 Q99572 4/20 0.39
MEN1 O00255 2/20 0.38
PRKD3 O94806 2/20 0.38
PRKCG P05129 2/20 0.38
PRKCB P05771 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
PRKCA P17252 2/20 0.38
NFKB1 P19838 2/20 0.38
PRKCH P24723 2/20 0.38
PRKCI P41743 2/20 0.38
PRKCE Q02156 2/20 0.38
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6213674 0.86 HTR7 (0.46) HTR7DRD2HTR2AHTR6HTR1A
SCHEMBL6219709 0.84 HTR7 (0.50) HTR7DRD2HTR2AHTR6HTR1A
SCHEMBL6213520 0.84 HTR7 (0.46) HTR7DRD2HTR2AHTR6HTR1A
SCHEMBL6213329 0.83 HTR7 (0.55) HTR7DRD2HTR2AHTR6HTR1A
SCHEMBL6215266 0.81 HTR7 (0.57) HTR7DRD2HTR2AHTR6HTR1A
SCHEMBL6213425 0.78 HTR7 (0.47) HTR7DRD2HTR2AHTR6HTR1A
SCHEMBL6216843 0.73 DRD2 (0.59) HTR7DRD2HTR2AHTR6HTR1A
SCHEMBL6218081 0.73 ADRA1A (0.52) HTR7DRD2HTR2AHTR6HTR1A
SCHEMBL6218064 0.73 ADRA1A (0.48) HTR7DRD2HTR2AHTR6HTR1A
SCHEMBL6219067 0.72 ADRA1A (0.51) HTR7DRD2HTR2AHTR6HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1122254-B1 4-Sulfonamide piperidine derivatives, method for their preparation and phamaceutical compositions containing them SERVIER LAB (FR) 2005-04-27 EP disclosed
US-6323217-B2 CARDIOVASCULAR DISORDERS ADIR ET COMPAGNIE (FR) 2001-11-27 US disclosed
US-20010034352-A1 Piperidine-4 sulphonamide compounds LES LABORATOIRES SERVIER (FR) 2001-10-25 US disclosed
EP-1122254-A2 4-Sulfonamide piperidine derivatives, method for their preparation and phamaceutical compositions containing them ADIR ET COMPAGNIE (FR) 2001-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010034352-A1 Piperidine-4 sulphonamide compounds KDR, GLS, FLT1 HTR7 164/4885DRD2 125/4885HTR2A 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.